The serum LDH level and KELIM scores are potential predictors of a benefit from bevacizumab first-line therapy for patients with advanced ovarian cancer
Article in Clinical and Translational Oncology (June 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Clinical and Translational Oncology (June 2024)
Article in Frontiers in Bioengineering and Biotechnology (March 2024)
Article in Biomedicine & Pharmacotherapy (May 2023)